Predicate |
Object |
contentType |
Journal Article |
endingPage |
23 |
issn |
2040-3429 |
issueIdentifier |
11 |
pageRange |
1313-23 |
publicationName |
Current opinion in investigational drugs (London, England : 2000) |
startingPage |
1313 |
bibliographicCitation |
Palmer AM. Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis. Curr Opin Investig Drugs. 2010 Nov;11(11):1313–23. PMID: 21157651. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bcdf70edbda3b521b4ef2d142cbbf59 |
date |
201011 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/21157651 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22279 https://portal.issn.org/resource/ISSN/2040-3429 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_591c2e8932411008249b2f31a8f2f46c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3899 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10606 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684141 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7578 |